Published: October 21, 2025 | From: Department for Science, Innovation and Technology, The Rt Hon Liz Kendall MP
AI Growth Labs: A New Era for Innovation
The UK government has introduced a transformative blueprint for AI regulation, announced by the Technology Secretary on October 21, 2025, aimed at fostering innovation, reducing bureaucratic hurdles, and enhancing public trust. This initiative, part of the government’s Plan for Change, seeks to unlock AI’s potential across key sectors like healthcare, professional services, transport, and advanced manufacturing.
Regulatory Sandboxes: Testing AI in Real-World Settings
At the Times Tech Summit, the Technology Secretary outlined plans for “AI Growth Labs,” regulatory sandboxes where companies can test AI products in controlled environments with relaxed regulations under strict oversight. These sandboxes will allow innovators to develop and deploy AI responsibly, accelerating adoption while maintaining safety and compliance.
Key Benefits for the Public
The blueprint promises significant improvements, including:
- Faster Housing Approvals: AI could streamline the 18-month, 4,000-page housing application process, supporting the government’s goal to build 1.5 million homes by the end of the current Parliament.
- Enhanced Healthcare: AI tools could reduce NHS waiting times, improve patient outcomes, and ease the burden on frontline staff.
- Professional Services Innovation: AI-driven advancements could transform industries, boosting efficiency and global competitiveness.
Image Source: UK Government, Department for Science, Innovation and Technology
Driving Economic Growth and Public Trust
Supporting Businesses and Innovation
The AI Growth Labs will provide a safe space to pilot AI innovations, generating real-world evidence of their impact. With only 21% of UK firms currently using AI, the initiative aims to boost adoption, potentially increasing productivity by 1.3% annually, equivalent to £140 billion, according to OECD estimates.
Healthcare and AI: A £1 Million Investment
A £1 million fund will support the Medicines and Healthcare products Regulatory Agency (MHRA) to pilot AI-assisted tools for drug discovery, clinical trials, and licensing. These tools aim to enhance efficiency while ensuring human oversight, maintaining safety and trust.
Strict Oversight and Global Leadership
The AI Growth Labs will operate under a strict licensing scheme, with safeguards to halt testing if risks emerge or terms are breached. This approach builds on the UK’s pioneering history with regulatory sandboxes, such as the FCA’s 2016 fintech sandbox, and aligns with global efforts in the EU, USA, Japan, Estonia, and Singapore.
Industry Support and Next Steps
Industry leaders, including representatives from A&O Shearman, Y Combinator, and TechUK, have praised the initiative for its potential to drive investment and growth. The government will now launch a public consultation to refine the AI Growth Lab proposals, exploring whether it should be government-led or managed by regulators.
Contact Information
For media inquiries, contact the Department for Science, Innovation and Technology at [email protected] or call 020 7215 3000 (Monday to Friday, 8:30am to 6pm).
Keyword: AI Growth Labs
Meta Description: UK government unveils AI Growth Labs to streamline regulations, boost innovation in healthcare, housing, and professional services, driving economic growth and public trust.